AGM/EGMApr 29, 2026, 04:34 PM
CADL 2026 Annual Meeting Set for June 23; Elects Directors
AI Summary
Candel Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 23, 2026. Stockholders will vote on the election of four Class II directors and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for voting is April 24, 2026, and proxy materials are being made available online.
Key Highlights
- Candel Therapeutics, Inc. (CADL) will hold its 2026 Annual Meeting of Stockholders virtually on June 23, 2026, at 10:00 a.m. Eastern Time.
- Stockholders will vote to elect four Class II directors to the board, serving until the 2029 annual meeting.
- The board has nominated Edward J. Benz, Jr., Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak for election as Class II directors.
- Stockholders will also ratify the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2026.
- Only stockholders of record as of April 24, 2026, are entitled to vote at the Annual Meeting.
- The company is using the "Notice and Access" rule, mailing a Notice of Internet Availability of Proxy Materials around April 29, 2026.
Price Impact
More from CADL